Fadraciclib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Uterine Cancer.

Fadraciclib is under clinical development by Cyclacel Pharmaceuticals and currently in Phase II for Unspecified B-Cell Lymphomas.

The hormone estrogen regulates binge drinking in females, causing them to "pregame," or consume large quantities of alcohol ...

Scientists mapped genomes of bed bug strains, identifying 729 mutations linked to insecticide resistance, offering insights ...

Download the revised NEET UG Biology Syllabus along with important topics, exam pattern and marks distribution. Know the ...

Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses ...

Living cells and tissues show a high capacity to absorb various chemical compounds from the surrounding environment. Although ...

A recent study suggests that intermittent fasting might have an unintended side effect—slowing down hair growth.

Toyota shifts focus from hydrogen cars to Atkinson cycle engines for improved efficiency and sustainability. Explore their strategic innovation toward eco-friendly mobility solutions.

In tumoral cells, the modulation of the G1/S phases of cell cycle is destabilized by amplification and high expression of cyclin E (CCNE) or by mutation or loss of retinoblastoma 1 (RB1) gene. Cancer ...